Request Appointment
1275 York AvenueNew York, NY 10065
Overview of Dr. Schmitt
Dr. Adam Schmitt is a radiation oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from University of Chicago Division of the Biological Sciences The Pritzker School of Medicine and has been in practice 8 years. He is one of 115 doctors at Memorial Sloan Kettering Cancer Center and one of 26 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Radiation Oncology. He has more than 30 publications and over 500 citings.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Radiation Oncology, 2010 - 2014
University of ChicagoResidency, Internal Medicine, 2009 - 2010
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2009
Certifications & Licensure
CA State Medical License 2010 - Present
FL State Medical License 2023 - Present
NJ State Medical License 2021 - 2027
NY State Medical License 2014 - 2026
IL State Medical License 2009 - 2010
American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Integration of Next Generation Sequencing Data to Inform Survival Prediction of Patients with Spine Metastasis.Alexandra Giantini-Larsen, Alexander D Ramos, Axel Martin, Katherine S Panageas, Caroline E Kostrzewa
Cancers. 2025-07-02 - Histologic Classifier of Radiosensitivity to Spine Stereotactic Body Radiation Therapy.Christopher B Jackson, Lillian A Boe, Lei Zhang, Aditya Apte, Andrew Jackson
International Journal of Radiation Oncology, Biology, Physics. 2025-06-16 - 1 citationsRadiation Myelitis Risk After Hypofractionated Spine Stereotactic Body Radiation Therapy.Christopher B Jackson, Lillian A Boe, Lei Zhang, Aditya Apte, Lisa M Ruppert
JAMA Oncology. 2025-02-01
Press Mentions
Reducing Cardiovascular Disease in Cancer SurvivorsDecember 24th, 2022- Mouse Study Suggests New Therapeutic Strategy to Reduce Cardiovascular Disease in Cancer SurvivorsDecember 19th, 2022
- New Discovery Could Reduce the Risk of Heart Damage Among Cancer PatientsDecember 19th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
